{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:59:33Z","timestamp":1778727573035,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.ygyno.2009.09.024","type":"journal-article","created":{"date-parts":[[2009,10,13]],"date-time":"2009-10-13T04:38:52Z","timestamp":1255408732000},"page":"92-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":268,"title":["Metformin is a potent inhibitor of endometrial cancer cell proliferation\u2014implications for a novel treatment strategy"],"prefix":"10.1016","volume":"116","author":[{"given":"Leigh A.","family":"Cantrell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Mendivil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly M.","family":"Malloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola A.","family":"Gehrig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria L.","family":"Bae-Jump","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2009.09.024_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2009.03.039","article-title":"Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship","volume":"114","author":"Fader","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2009.09.024_bib2","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.ajog.2005.03.038","article-title":"The impact of obesity and age on quality of life in gynecologic surgery","volume":"193","author":"von Gruenigen","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2009.09.024_bib3","first-page":"71","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.ygyno.2009.09.024_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1525-1438.2007.00790.x","article-title":"Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis","volume":"17","author":"Chia","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"17","key":"10.1016\/j.ygyno.2009.09.024_bib5","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2009.09.024_bib6","first-page":"95","article-title":"Diabetes mellitus is a multivariate independent prognostic factor in endometrial carcinoma: a clinicopathologic study on 313 patients","volume":"28","author":"Steiner","year":"2007","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"7503","key":"10.1016\/j.ygyno.2009.09.024_bib7","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ygyno.2009.09.024_bib8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2337\/diacare.29.02.06.dc05-1558","article-title":"Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin","volume":"29","author":"Bowker","year":"2006","journal-title":"Diabetes Care"},{"issue":"5754","key":"10.1016\/j.ygyno.2009.09.024_bib9","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1126\/science.1120781","article-title":"The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin","volume":"310","author":"Shaw","year":"2005","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ygyno.2009.09.024_bib10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/GRF.0b013e31802f35a0","article-title":"Pharmacologic therapy of polycystic ovary syndrome","volume":"50","author":"Dronavalli","year":"2007","journal-title":"Clin. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2009.09.024_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2008.01.007","article-title":"Targeting AMPK: a new therapeutic opportunity in breast cancer","volume":"67","author":"Hadad","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"4","key":"10.1016\/j.ygyno.2009.09.024_bib12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.molmed.2006.02.003","article-title":"LKB1: a sweet side to Peutz\u2013Jeghers syndrome?","volume":"12","author":"Carling","year":"2006","journal-title":"Trends Mol. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2009.09.024_bib13","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1158\/0008-5472.CAN-07-5014","article-title":"Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas","volume":"68","author":"Contreras","year":"2008","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.ygyno.2009.09.024_bib14","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1158\/1078-0432.CCR-07-0321","article-title":"Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma","volume":"14","author":"Lu","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.ygyno.2009.09.024_bib15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","article-title":"Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers","volume":"92","author":"Mutter","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.ygyno.2009.09.024_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-2559.2002.01455.x","article-title":"Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclin-dependent kinase inhibitor, p27","volume":"41","author":"An","year":"2002","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.ygyno.2009.09.024_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1677\/erc.0.0100203","article-title":"Loss of PTEN expression followed by Akt phosphorylation is a poor prognostic factor for patients with endometrial cancer","volume":"10","author":"Terakawa","year":"2003","journal-title":"Endocr.-Relat. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2009.09.024_bib18","first-page":"452","article-title":"Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay","volume":"6","author":"Bieche","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.ygyno.2009.09.024_bib19","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1093\/emboj\/16.12.3693","article-title":"Rapamycin suppresses 5\u2032TOP mRNA translation through inhibition of p70s6k","volume":"16","author":"Jefferies","year":"1997","journal-title":"EMBO J."},{"issue":"18","key":"10.1016\/j.ygyno.2009.09.024_bib20","doi-asserted-by":"crossref","first-page":"10320","DOI":"10.1073\/pnas.171060098","article-title":"An inhibitor of mTOR reduces neoplasia and normalizes p70\/S6 kinase activity in Pten+\/\u2212 mice","volume":"98","author":"Podsypanina","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"17","key":"10.1016\/j.ygyno.2009.09.024_bib21","first-page":"5027","article-title":"Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779","volume":"62","author":"Shi","year":"2002","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.ygyno.2009.09.024_bib22","first-page":"6141","article-title":"Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells","volume":"62","author":"Grunwald","year":"2002","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.ygyno.2009.09.024_bib23","doi-asserted-by":"crossref","first-page":"10314","DOI":"10.1073\/pnas.171076798","article-title":"Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP\/mTOR","volume":"98","author":"Neshat","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.ygyno.2009.09.024_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/1940-6207.CAPR-08-0081","article-title":"The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase","volume":"1","author":"Zakikhani","year":"2008","journal-title":"Cancer Prev. Res. (Phila Pa)"},{"issue":"21","key":"10.1016\/j.ygyno.2009.09.024_bib25","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1158\/0008-5472.CAN-06-1500","article-title":"Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells","volume":"66","author":"Zakikhani","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ygyno.2009.09.024_bib26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2008.04.008","article-title":"In vitro metformin anti-neoplastic activity in epithelial ovarian cancer","volume":"110","author":"Gotlieb","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"22","key":"10.1016\/j.ygyno.2009.09.024_bib27","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1158\/0008-5472.CAN-07-2310","article-title":"Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells","volume":"67","author":"Dowling","year":"2007","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.ygyno.2009.09.024_bib28","first-page":"789","article-title":"Rapamycin inhibits telomerase activity by decreasing the hTERT mRNA level in endometrial cancer cells","volume":"2","author":"Zhou","year":"2003","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.ygyno.2009.09.024_bib29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2005.08.053","article-title":"Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest","volume":"100","author":"Bae-Jump","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2009.09.024_bib30","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4161\/cc.8.6.7933","article-title":"Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro","volume":"8","author":"Alimova","year":"2009","journal-title":"Cell Cycle"},{"issue":"25","key":"10.1016\/j.ygyno.2009.09.024_bib31","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1038\/sj.onc.1211024","article-title":"The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level","volume":"27","author":"Ben Sahra","year":"2008","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.ygyno.2009.09.024_bib32","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1158\/0008-5472.CAN-06-4447","article-title":"Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth","volume":"67","author":"Buzzai","year":"2007","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ygyno.2009.09.024_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1006\/scbi.2000.0339","article-title":"Telomerase and human tumorigenesis","volume":"10","author":"Stewart","year":"2000","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.ygyno.2009.09.024_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/gyno.1997.4921","article-title":"Telomerase activity in the female reproductive tract and neoplasms","volume":"68","author":"Yokoyama","year":"1998","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2009.09.024_bib35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/gyno.1996.4523","article-title":"Telomerase activity in gynecologic tumors","volume":"64","author":"Zheng","year":"1997","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2009.09.024_bib36","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1073\/pnas.93.12.6091","article-title":"Cell cycle-dependent modulation of telomerase activity in tumor cells","volume":"93","author":"Zhu","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"20","key":"10.1016\/j.ygyno.2009.09.024_bib37","doi-asserted-by":"crossref","first-page":"10687","DOI":"10.1073\/pnas.94.20.10687","article-title":"Lack of cell cycle regulation of telomerase activity in human cells","volume":"94","author":"Holt","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.ygyno.2009.09.024_bib38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-199630050-00003","article-title":"Clinical pharmacokinetics of metformin","volume":"30","author":"Scheen","year":"1996","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.ygyno.2009.09.024_bib39","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.ATV.0000201938.78044.75","article-title":"Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells","volume":"26","author":"Isoda","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.ygyno.2009.09.024_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/00498259409043220","article-title":"Accumulation of metformin by tissues of the normal and diabetic mouse","volume":"24","author":"Wilcock","year":"1994","journal-title":"Xenobiotica"},{"issue":"5930","key":"10.1016\/j.ygyno.2009.09.024_bib41","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809007239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809007239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:25:23Z","timestamp":1758770723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825809007239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0090825809007239"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2009.09.024","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin is a potent inhibitor of endometrial cancer cell proliferation\u2014implications for a novel treatment strategy","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2009.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}